X
Home > Journals > Cancer Biotherapy and Radiopharmaceuticals Impact Factor, Quartile, Indexing, Ranking
Cancer Biotherapy and Radiopharmaceuticals (CBR) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by SAGE. The Print-ISSN of Cancer Biotherapy and Radiopharmaceuticals is 10849785
Cancer Biotherapy and Radiopharmaceuticals is published by SAGE, publishing since 1996. It covers research in Pharmacology, Toxicology and Pharmaceutics, Medicine, Biochemistry Genetics and Molecular Biology.
The journal is indexed in Scopus.
| Journal title | Cancer Biotherapy and Radiopharmaceuticals (CBR) |
| Print ISSN | 10849785 |
| Online ISSN | 15578852 |
| Publisher Name | SAGE |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🔒 Subscription |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Cancer Biotherapy and Radiopharmaceuticals
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
Add the app to your device for one-tap access.
